Ifp Advisors, Inc Bio Atla, Inc. Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$2.3 - $8.25 $20 - $74	-9 Reduced 4.71%	182 $0
Q4 2022 Feb 07, 2023	BUY	$6.29 - $11.01 $56 - $99	9 Added 4.95%	191 $6,000
Q2 2022 Sep 06, 2022	BUY	$2.13 - $5.38 $387 - $979	182 New	182 $6,000
Q2 2022 Aug 12, 2022	SELL	$2.13 - $5.38 $387 - $979	-182 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$4.38 - $18.78 $797 - $3,417	182 New	182 $0

23.4M

30.8K

57K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $12.7M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.